Your browser doesn't support javascript.
loading
Research progress on chemical compositions and pharmacological action of Drynariae Rhizoma / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 2737-2745, 2021.
Article in Chinese | WPRIM | ID: wpr-887944
ABSTRACT
Drynariae Rhizoma is warm in nature and bitter in taste, mainly acting on liver and kidney systems. It is a common Chinese herbal medicine for the treatment of fracture and bone injury. The chemical compositions of Drynariae Rhizoma mainly include flavonoids, triterpenoids, phenylpropanoids and lignans. At present, modern pharmacological and clinical studies have shown that Drynariae Rhizoma has the effects of anti osteoporosis, promoting fracture healing, kidney protection, anti-inflammatory, promoting tooth growth, preventing and treating aminoglycoside ototoxicity and lowering blood lipid. In addition, the toxicity evaluation experiment of Drynariae Rhizoma has also shown that it has no obvious toxic and side effects. Naringin is a kind of dihydroflavone in Drynariae Rhizoma. Many studies have shown that naringin and other total flavonoids play an important role in anti-osteoporosis, promoting fracture healing, anti-inflammation, promoting tooth growth and lowering blood lipid. In this study, the research progresses on chemical consti-tuents and pharmacological activities of Drynariae Rhizoma in recent years were reviewed, and some mechanisms of action were summarized, to provide references for the further research and development of Drynariae Rhizoma.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Osteoporosis / Flavonoids / Drugs, Chinese Herbal / Polypodiaceae / Rhizome Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Osteoporosis / Flavonoids / Drugs, Chinese Herbal / Polypodiaceae / Rhizome Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2021 Type: Article